Furthermore, elevated alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin (TB) levels have been found in 15–16% of COVID-19 patients [2], with 44% showing abnormal liver function tests. This evidence concerns the gene GPT and COVID-19.